Do you have cancer with a MET alteration?

Learn about an investigational drug designed to target the c-Met pathway and slow tumor growth in the SPARTA study. If you have non-small cell lung cancer (NSCLC), brain cancer, or another advanced solid tumor, you may qualify.

Learn More Do I Qualify?